CD44 and neoplasm: Presumably, the mechanisms for regulating the CD44+/CD24−/low cells are not easily altered in the non-tumorigenic population vs. cancer cells, suggesting a potentially pivotal role for this enrichment in tumor re-growth following radiation therapy.